No image published for this recall

No image published for this recall

Inhibin b gen ii elisa

Official notice

6 Mar 2025

Last checked

6 Mar 2025

Medium riskHealth Canada

An official Health Canada notice concerns Inhibin b gen ii elisa. Beckman Coulter has determined that the affected Inhibin B Gen II ELISA reagent lots may provide elevated results. This increase is not detectable by kit controls. Their investigational data confirmed an average increase of about 15% with the maximum reported increase of an individual sample of +44%. Recall Start Date: February 17, 2025 Published 2025-03-06.

What to do now

Contact the manufacturer if you require additional information.

Recall number

77068

Official notice

2025-03-06

The hazard

Beckman Coulter has determined that the affected Inhibin B Gen II ELISA reagent lots may provide elevated results. This increase is not detectable by kit controls. Their investigational data confirmed an average increase of about 15% with the maximum reported increase of an individual sample of +44%. Recall Start Date: February 17, 2025

How to check if you're affected

Compare the product name and identifiers below with the item you own. Follow the official notice if they match.

Recall Numbers

77068

Checked manually this time?

The app alerts you when a new official recall is published — no searching, no checking back.

Turn on recall alerts

Affected products

Product 1

Affected products - Inhibin B Gen II ELISA, Lot or serial number - 240918D 241022D 241205C 241108C 241022C 241212C, Model or catalog number - A81303

Risk / hazard

Beckman Coulter has determined that the affected Inhibin B Gen II ELISA reagent lots may provide elevated results. This increase is not detectable by kit controls. Their investigational data confirmed an average increase of about 15% with the maximum reported increase of an individual sample of +44%. Recall Start Date: February 17, 2025

Where it was sold

The source does not list specific retailers. See the official notice for where affected products were sold.

Location 1

CA · Canada

Affected area 1

CA · Canada

Company & contacts

Manufacturer

Not provided

Phone

Not provided

Brand: Immunotech S.r.o, Inhibin B Gen Ii Elisa.

Source & status

Source

Health Canada

Tier

official

Category

HOME

Classification

Type II

App estimate

medium

Recall details

Recall number

77068

Classification

Type II

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Related recalls

CA
No image published for this recall

Estrone ria kits

Medium riskHealth Canada18 Jun 2025
CA
No image published for this recall

Estrone ria kits

Medium riskHealth Canada18 Jun 2025
CA
No image published for this recall

Nephromax high pressure nephrostomy balloon catheter

Medium riskHealth Canada2 Jul 2026
CA
No image published for this recall

Atellica ch enzymatic hemoglobin a1c (a1c e) assay

Medium riskHealth Canada18 Jun 2026
CA
Cannapiece corp. Recalls jays - pink pennifer 0.4g all-in-one vape due to labelling issueImage: Health Canada recall notice

Cannapiece corp. Recalls jays - pink pennifer 0.4g all-in-one vape due to labelling issue

Critical riskHealth Canada20 May 2026
CA
No image published for this recall

Bard silastic® foley catheter

Medium riskHealth Canada6 May 2026
CA
No image published for this recall

Quickvue® dipstick strep a test

Medium riskHealth Canada10 Apr 2026

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.

This recall was published 6 Mar 2025. The next one won't wait for you to search.

RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.